Downregulation of PEBP1 in rat brain cortex in hypoxia.
In order to understand dementia and other ailments associated with high altitude hypoxia, adult Sprague Dawley male rats were exposed to simulated conditions of high altitude (7,500 m above sea level, 59 mmHg) for a period of 5 days and analyzed for changes in neuronal proteome by 2-D sodium dodecyl sulfate polyacrylamide gel electrophoresis. Protein extracts obtained from the brain cortex and hippocampus of the hypoxic rats were separated by 2-D gel electrophoresis. Differentially expressed proteins (analysis by 2-D gel analysis software, Bio-2D, Vilber-Lourmat, France and Delta2d, Decodon, Germany) were subjected to matrix-assisted laser desorption/ionization time-of-flight analysis. Among the proteins identified, the spot corresponding to pI 5.4 and molecular weight 21 kDa, identified as phosphatidylethanolamine binding protein (PEBP1), was consistently lowered (54%) in hypoxic cortex samples. PEBP1, also known as Raf kinase inhibitor protein, is a precursor of hippocampus cholinergic neurostimulatory peptide (HCNP). Western blot analysis revealed elevated phospho-extracellular signal-regulated kinase in hypoxic rat cortex samples, indicating activation of Raf/mitogen-activated protein kinase pathway under hypoxia. Lowered HCNP levels leading to 23% decrease in choline acetyltransferase and 63% increase in acetylcholinesterase activity were detected in hypoxic rat brain cortex, while no significant change was noted in hippocampus. Since PEBP1 is lowered in a number of neurological disorders associated with dementia, we speculate that lowered expression of PEBP1 might be responsible for dementia associated with high-altitude hypoxia. Further studies targeting PEBP1 might give clues about signaling pathways associated with hypoxia and dementia.
Burgula
Sandeepta
S
Department of Biochemistry, Osmania University, Hyderabad, 500007, Andhra Pradesh, India.
Medisetty
Rajesh
R
Jammulamadaka
Nalini
N
Musturi
Sairam
S
Ilavazhagan
Govindan
G
Singh
Surya S
SS
D000110:Acetylcholinesterase / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism*; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D015536:Down-Regulation; D015180:Electrophoresis, Gel, Two-Dimensional; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism*; D000860:Hypoxia / Q000378:metabolism*; D008297:Male; D013058:Mass Spectrometry / Q000379:methods; D008969:Molecular Sequence Data; D009479:Neuropeptides / Q000378:metabolism; D049488:Phosphatidylethanolamine Binding Protein / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D009479:Neuropeptides; C550693:PEBP1 protein, rat; D049488:Phosphatidylethanolamine Binding Protein; C075274:hippocampal cholinergic neurostimulating peptide; D002795:Choline O-Acetyltransferase; D048049:Extracellular Signal-Regulated MAP Kinases; D000110:Acetylcholinesterase
J Biol Chem. 2004 Oct 29;279(44):45855-64
15302887
High Alt Med Biol. 2008 Spring;9(1):63-75
18331222
Am J Physiol. 1998 Sep;275(3):L461-8
9728040
Wien Med Wochenschr. 2002;152(3-4):72-6
11925775
J Neurosci Res. 1996 Aug 01;45(3):202-15
8841981
Brain Res Dev Brain Res. 2001 Jan 31;126(1):117-20
11172893
Biochem Pharmacol. 1961 Jul;7:88-95
13726518
Brain Res. 2003 Mar 7;965(1-2):194-202
12591138
J Neurochem. 1988 Jun;50(6):1914-23
3373218
J Neurochem. 1978 Oct;31(4):757-60
212531
Int J Sports Med. 1993 May;14(4):232-4
8325724
Am J Med. 2006 Feb;119(2):168.e1-6
16443427
Circ Res. 1996 Jan;78(1):82-90
8603510
Neurobiol Aging. 2006 Apr;27(4):614-23
15941609
Nat Med. 1995 Oct;1(10):1082-5
7489367
Brain Res. 1996 Jan 8;706(1):57-70
8720492
Behav Brain Res. 2007 Feb 27;177(2):308-14
17218023
J Neurochem. 2006 Nov;99(4):1133-41
17018026
Oncol Rep. 2006 Sep;16(3):451-6
16865242
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 May 5;819(1):115-29
15797529
J Biol Chem. 1968 Jul 25;243(14):3864-70
5690817
Int J Biometeorol. 1966 Jul;10(1):63-9
6003442
J Biol Chem. 2003 Apr 11;278(15):13061-8
12551925
Alzheimer Dis Assoc Disord. 1995;9 Suppl 2:23-8
8534419
Anal Biochem. 1984 Apr;138(1):141-3
6731838
Electrophoresis. 1999 Dec;20(18):3551-67
10612281
Anal Biochem. 1976 May 7;72:248-54
942051
Methods Mol Biol. 1997;64:165-73
9116819
Proc Natl Acad Sci U S A. 1984 Apr;81(8):2567-71
6585816
J Neuropathol Exp Neurol. 2002 Feb;61(2):176-85
11853019
J Biol Chem. 2004 Mar 26;279(13):13054-64
14724289
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18727-32
17121991
J Biol Chem. 2001 Jan 5;276(1):535-40
11034991
J Clin Invest. 1990 Sep;86(3):900-8
2394839
Mol Cell Biol. 2000 May;20(9):3079-85
10757792
Cell Signal. 2008 May;20(5):935-41
18294816
Brain Res. 1991 Jul 19;554(1-2):264-71
1933308
Biol Reprod. 2002 Jul;67(1):232-9
12080022
Cell Signal. 2008 Jan;20(1):1-9
17706925
Adv Cancer Res. 2004;91:169-200
15327891
Prog Neurobiol. 2003 Feb;69(3):193-211
12758110
Nature. 1999 Sep 9;401(6749):173-7
10490027
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17213-8
16275899
J Neurochem. 2002 Oct;83(2):331-45
12423243